MetLife SEC Filings

MetLife, Inc. reported that its Board of Directors increased its size from eleven to thirteen members and elected Daniel S. Glaser and Michelle R. Seitz as new directors effective February 24, 2026. Both were also appointed to multiple key Board committees and were determined to be independent directors.

Each new director will receive MetLife’s standard non-management director compensation, which currently consists of a $355,000 annual retainer, with $205,000 paid in common stock and $150,000 paid in cash. Retainers are pro-rated for partial-year service, with the first of four annual installments earned at the beginning of service.

MetLife, Inc. is offering fixed-to-fixed reset rate subordinated debentures due 2056 via a preliminary prospectus supplement dated February 24, 2026, supplementing the May 16, 2025 prospectus. The securities are unsecured, subordinated obligations that rank pari passu with the 2055 SDs and junior to MetLife’s senior indebtedness and subsidiary liabilities. Interest is payable semi-annually and initially fixed through the Initial Interest Reset Date, thereafter resetting each five years to the Five-Year Treasury Rate plus a spread. MetLife may defer interest for up to five consecutive years per Optional Deferral and may redeem the Debentures under specified conditions, including Tax, Rating Agency or Regulatory Capital Events. The Debentures will be issued in book-entry form and are not listed on any exchange.

MetLife, Inc.’s board is reporting beneficial ownership of 105,374,380 shares, or 16.2% of the company’s common stock, through the MetLife Policyholder Trust. This ownership reflects shares held in the name of Wilmington Trust Company as trustee for eligible policyholders.

The trust was originally issued 494,466,664 shares on April 7, 2000 under MetLife’s demutualization plan, but transactions by beneficiaries, a 2008 split-off, withdrawals, and escheatment have reduced the holdings to the current level as of February 12, 2026. The board is deemed to share voting power because the trustee generally follows board voting recommendations, except on defined “Beneficiary Consent Matters,” where votes reflect beneficiary instructions.

Beneficiaries hold fractional trust interests rather than legal title to the shares, but they are entitled to dividends and proceeds from sales of their allocated shares. Between October 31, 2025 and the current report, beneficiary-related activity decreased the trust’s holdings from 106,549,803 to 105,374,380 shares.

MetLife, Inc. presents its annual report describing how it plans to grow under its four-year New Frontier strategy, focusing on group benefits, retirement platforms, asset management and international markets. The company reorganized into six segments and elevated MetLife Investment Management (MIM) to a reportable segment.

MetLife completed the acquisition of global asset manager PineBridge Investments to add scale and broaden investment products and distribution for institutional clients. The filing also details extensive U.S. and international insurance, capital and solvency regulation, climate and cybersecurity oversight, and data privacy rules that shape MetLife’s capital, product, and risk management decisions worldwide.

MetLife, Inc. declared a series of preferred stock dividends for first quarter 2026. The company approved a semi-annual dividend of $29.375 per share on its 5.875% fixed-to-floating rate preferred stock, Series D, and quarterly dividends of $351.5625 per share on Series E and $296.875 per share on Series F, with holders of the related depositary shares receiving $0.3515625 and $0.296875 per share, respectively. MetLife also declared a quarterly dividend of $0.31501229 per share on its floating rate preferred stock, Series A, subject to final confirmation that it has met specified financial tests. All these dividends are payable on March 16, 2026, to shareholders of record as of February 27, 2026.

MetLife, Inc. filed a Form 13F reporting holdings as a 13F Combination Report that lists 6 Form 13F information table entries with a total reported value of $12,153,950.

The filing is submitted on behalf of MetLife investment managers and is signed by John McCallion, EVP, CFO and Head of MetLife Investment Management.

MetLife, Inc. furnished its quarterly and full-year 2025 earnings materials and provided an updated multi-year outlook. The company reported $3.6 billion of cash and liquid assets at its holding companies as of December 31, 2025, which is within its $3.0 billion to $4.0 billion target range, and plans to maintain this target in 2026.

MetLife states it returned approximately $4.4 billion to shareholders in 2025 and remains on track to generate about $25.0 billion of free cash flow over 2025–2029. Assuming a 10-year U.S. Treasury rate of 4.40% at December 31, 2026, S&P 500 annual returns of 5% and private equity returns of 9% in 2026, it estimates $1.6 billion of pre-tax variable investment income for 2026 and expects its two-year average free cash flow to adjusted earnings ratio to stay at 65%–75%. The company is maintaining near-term annual targets for adjusted return on equity of 15%–17%, double-digit adjusted earnings per share growth, and direct expense ratio targets of 12.1% for 2026 and 11.3% in 2029, while indicating it does not expect material liquidity deficiencies or covenant issues.

MetLife (MET) filed a notice of proposed stock sales under Rule 144. The filing covers the potential sale of 562 shares of common stock through Bernstein Institutional Services LLC on the NYSE, with an aggregate market value of $44,836.36.

The shares to be sold were originally acquired on May 29, 2015 in a cash purchase from Goldman Sachs, with payment completed on June 3, 2015. The planned sale date is approximately January 9, 2026.

The notice also lists prior sales of MetLife common stock during the past three months by MetLife 401k Plan and several MetLife separate accounts, including blocks such as 359 shares sold on December 19, 2025 by MetLife 401k Plan Trust-Large Cap Equity Index for gross proceeds of $29,283.63.

MetLife, Inc. has reorganized its business structure to highlight growth in asset management. In the fourth quarter of 2025, the company made MetLife Investment Management (MIM), its institutional asset management unit, a separate reportable segment, while MetLife Holdings is no longer a reportable segment and is now mainly included in Corporate & Other. Certain products formerly in MetLife Holdings have been reclassified into Group Benefits and Retirement and Income Solutions (RIS).

Following these changes, MetLife is now organized into six segments: Group Benefits, RIS, Asia, Latin America, Europe, the Middle East and Africa, and MIM, with additional results in Corporate & Other. Effective January 1, 2025, MetLife also amended agreements between MIM and MetLife entities so that MIM manages general account assets at current market fee rates, compared with 2024 terms. The company states that these updates did not change prior period consolidated net income or consolidated adjusted earnings and has provided a Historical Results Financial Supplement to help investors compare past periods under the new structure.